Halozyme Therapeutics, Inc. - Common Stock (NQ:HALO)
Price and Volume
Detailed Quote| Volume | 1,606,582 |
| Open | 118.35 |
| Bid (Size) | 121.21 (100) |
| Ask (Size) | 121.32 (700) |
| Prev. Close | 116.82 |
| Today's Range | 117.38 - 122.33 |
| 52wk Range | 61.23 - 119.21 |
| Shares Outstanding | 142,334,900 |
| Dividend Yield | N/A |
Top News
More News
Performance
52-Week Range
121.21
61.2352W Low
119.2152W High
1 Week
107.411W Low
119.211W High
Halozyme Therapeutics, Inc. - Common Stock (HALO) traded between $61.23 and $119.21 over the past 52 weeks and last traded at $121.21. Over the past week it ranged between $107.41 and $119.21.
Past 12 Months
1W
+$11.37
1M
+$13.27
3M
+$45.39
6M
+$53.16
YTD
+$50.90
1Y
+$54.56
HALO was +81.9% over the past year, +78.1% over six months, +72.4% year to date, +10.4% in the last week.
12 Months vs Market
HALO
+81.9%
DIA
+12.8%
SPY
+16.7%
QQQ
+21.8%
IWM
+10.9%
Over the past 12 months HALO returned +81.9% versus DIA (Dow) +12.8%, SPY (S&P 500) +16.7%, QQQ (Nasdaq 100) +21.8% and IWM (Russell 2000) +10.9%.
Volume & Liquidity
0.72× 3-mo avg
Today 1,606,582
3-mo avg 2.2M
1W
2.3M
1M
2.7M
3M
2.2M
6M
2.0M
YTD
2.0M
1Y
2.0M
HALO most recently traded 1,606,582 shares against a 3-month average daily volume of 2.2M.
More News
Read More
Biogen (NASDAQ:BIIB) Q2 Earnings: Leading The Therapeutics Pack
September 24, 2026
1 Cash-Producing Stock to Target This Week and 2 We Question
September 22, 2026
1 Mid-Cap Stock on Our Watchlist and 2 We Avoid
August 31, 2026
3 Market-Beating Stocks for Long-Term Investors
August 28, 2026
1 Healthcare Stock with Exciting Potential and 2 We Avoid
August 27, 2026
2 Mid-Cap Stocks with Solid Fundamentals and 1 Facing Challenges
August 24, 2026
Halozyme (HALO) Q2 2026 Earnings Call Transcript ↗
August 13, 2026
1 Profitable Stock to Research Further and 2 We Ignore
August 07, 2026
Halozyme Therapeutics Q2 Earnings Call Highlights ↗
August 06, 2026
What To Expect From Halozyme Therapeutics’s (HALO) Q2 Earnings
August 04, 2026
3 Growth Stocks Set to Flourish
August 03, 2026
1 Cash-Producing Stock on Our Watchlist and 2 We Ignore
July 24, 2026
1 Value Stock Worth Investigating and 2 Facing Headwinds
July 15, 2026
Frequently Asked Questions
Is Halozyme Therapeutics, Inc. - Common Stock publicly traded?
Yes, Halozyme Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Halozyme Therapeutics, Inc. - Common Stock trade on?
Halozyme Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Halozyme Therapeutics, Inc. - Common Stock?
The ticker symbol for Halozyme Therapeutics, Inc. - Common Stock is HALO on the Nasdaq Stock Market
What is the current price of Halozyme Therapeutics, Inc. - Common Stock?
The current price of Halozyme Therapeutics, Inc. - Common Stock is 121.21
When was Halozyme Therapeutics, Inc. - Common Stock last traded?
The last trade of Halozyme Therapeutics, Inc. - Common Stock was at 10/15/26 03:23 PM ET
What is the market capitalization of Halozyme Therapeutics, Inc. - Common Stock?
The market capitalization of Halozyme Therapeutics, Inc. - Common Stock is 17.25B
How many shares of Halozyme Therapeutics, Inc. - Common Stock are outstanding?
Halozyme Therapeutics, Inc. - Common Stock has 17B shares outstanding.